Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: DaShenLin Pharmaceutical Group Co., Ltd.

Market Cap 18.73B 2.76B 2.4B 2.21B 2.07B 3.87B 265B 3.95B 26.38B 10.21B 128B 10.38B 10.16B 444B P/E Ratio 2026 *
12.6x
P/E Ratio 2027 * 11x
Enterprise Value 15.21B 2.25B 1.95B 1.8B 1.68B 3.14B 215B 3.21B 21.43B 8.3B 104B 8.43B 8.25B 360B EV / Sales 2026 *
0.51x
EV / Sales 2027 * 0.45x
Free-Float
34.77%
Yield 2026 *
5.36%
Yield 2027 * 5.68%
1 week+2.30%
Current month-0.30%
1 month-12.50%
3 months-14.90%
6 months-4.36%
Current year-6.64%
1 week 15.57
Extreme 15.57
16.54
1 month 15.34
Extreme 15.34
18.88
Current year 15.34
Extreme 15.34
21.78
1 year 15.34
Extreme 15.34
21.78
3 years 11.92
Extreme 11.92
30.22
5 years 11.92
Extreme 11.92
39.47
10 years 11
Extreme 11.0028
61.63
Manager TitleAgeSince
Chief Executive Officer 44 2019-02-27
Director of Finance/CFO 44 2018-05-09
Human Resources Officer 48 -
Director TitleAgeSince
Chairman 59 2013-07-15
Director/Board Member 63 2016-08-07
Chairman 48 2015-05-27
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+2.30%-0.84%-38.71% 2.77B
+0.58%+0.58%-8.26%-22.68% 15.56B
+2.35%-2.79%-26.53%-27.14% 7.18B
-1.29%+1.50%-17.54%-11.46% 5.85B
-1.47%+5.69%-18.10%-28.21% 3.78B
-0.24%-0.22%-37.51%-9.80% 3.33B
-1.21%-2.33%-25.36%-45.30% 3.3B
+2.64%+5.59%+113.69% - 2.66B
0.00%-1.48%-25.09%-6.16% 2.56B
+2.97%+3.57%+5.25%+42.57% 1.7B
Average +0.43%+1.45%-4.03%-16.32% 4.87B
Weighted average by Cap. +0.41%+0.70%-9.33%-20.73%

Financials

2026 *2027 *
Net sales 29.97B 4.42B 3.84B 3.54B 3.32B 6.19B 424B 6.32B 42.21B 16.34B 204B 16.6B 16.25B 710B 33.01B 4.87B 4.23B 3.9B 3.65B 6.82B 467B 6.97B 46.49B 18B 225B 18.29B 17.9B 782B
Net income 1.48B 219M 190M 175M 164M 307M 20.98B 313M 2.09B 809M 10.11B 823M 805M 35.16B 1.7B 251M 218M 201M 188M 352M 24.06B 359M 2.4B 928M 11.6B 943M 923M 40.32B
Net Debt -3.52B -519M -451M -415M -389M -727M -49.73B -743M -4.96B -1.92B -23.97B -1.95B -1.91B -83.35B -4.01B -592M -514M -473M -444M -829M -56.66B -846M -5.65B -2.19B -27.31B -2.22B -2.17B -94.97B
Logo DaShenLin Pharmaceutical Group Co., Ltd.
DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company is mainly engaged in the chain retail business of Chinese and Western patent medicines, ginseng and antler tonic medicinal materials and Chinese herbal medicine slices, health products, medical devices and other commodities. The Company is also involved in the production of Chinese herbal medicine slices, ginseng and antler tonic, health products, Chinese and Western patent medicines. The Company's brands include Dong Zi Yun Xuan, Cocoking, Nobe Huale, Dongteng Ejiao, and Fuer. The Company mainly conducts business within domestic market.
Employees
41,141
Date Price Change Volume
26-06-11 16.45 ¥ 0.00% 5,182,573
26-06-10 16.45 ¥ +3.85% 6,503,179
26-06-09 15.84 ¥ +0.32% 5,742,741
26-06-08 15.79 ¥ -0.88% 6,087,934
26-06-05 15.93 ¥ -0.93% 6,286,822
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
16.45CNY
Average target price
24.49CNY
Spread / Average Target
+48.86%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 603233 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!